SEC Form 4 · accession 0001179110-17-002382

MEDICINES CO /DE · MDCO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Financial Officer

Period of report

Feb 10, 2017

Accepted (ET)

Feb 14, 2017 · 5:46 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001113481

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Feb 10, 2017	M	15,000	$19.06	A	35,102	D
Common Stock^F1	Feb 10, 2017	S	15,000	$50.00	D	20,102	D
Common Stock	Feb 10, 2017	M	15,907	$19.36	A	36,009	D
Common Stock^F1	Feb 10, 2017	S	15,907	$50.00	D	20,102	D
Common Stock	Feb 10, 2017	M	10,313	$31.49	A	30,415	D
Common Stock^F1	Feb 10, 2017	S	10,313	$50.00	D	20,102	D
Common Stock	Feb 10, 2017	M	16,282	$30.55	A	36,384	D
Common Stock^F1	Feb 10, 2017	S	16,282	$50.00	D	20,102	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (right-to-buy)^F6,F2	$19.06	Feb 10, 2017	M	15,000	D	—	Oct 15, 2017	Common Stock	15,000	0	D
Stock Option (right-to-buy)^F6,F3	$19.36	Feb 10, 2017	M	15,907	D	—	Feb 15, 2018	Common Stock	15,907	0	D
Stock Option (right-to-buy)^F6,F4	$31.49	Feb 10, 2017	M	10,313	D	—	Mar 1, 2023	Common Stock	10,313	448	D
Stock Option (right-to-buy)^F6,F5	$30.55	Feb 10, 2017	M	16,282	D	—	Mar 1, 2024	Common Stock	16,282	6,705	D

F1Sales were effected pursuant to a Rule 10b5-1 program adopted by the reporting person.
F2This option vested in forty-eight equal monthly installments beginning November 15, 2007.
F3This option vested in forty-eight equal monthly installments beginning March 15, 2008.
F4This option vested in forty-eight equal monthly installments beginning April 1, 2013.
F5This option vested in forty-eight equal monthly installments beginning April 1, 2014.
F6Not applicable.